Hubei Biocause Pharmaceutical Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Wenxia Zhou
Chief executive officer
CN¥2.0m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 4.5yrs |
| CEO ownership | n/a |
| Management average tenure | no data |
| Board average tenure | 4.4yrs |
Recent management updates
Recent updates
Hubei Biocause Pharmaceutical Co., Ltd.'s (SZSE:000627) Shares Leap 43% Yet They're Still Not Telling The Full Story
Oct 23
Further Upside For Hubei Biocause Pharmaceutical Co., Ltd. (SZSE:000627) Shares Could Introduce Price Risks After 32% Bounce
Sep 05Improved Revenues Required Before Hubei Biocause Pharmaceutical Co., Ltd. (SZSE:000627) Shares Find Their Feet
Jun 10Fewer Investors Than Expected Jumping On Hubei Biocause Pharmaceutical Co., Ltd. (SZSE:000627)
Mar 05CEO
Wenxia Zhou (52 yo)
4.5yrs
Tenure
CN¥2,015,000
Compensation
Ms. Wenxia Zhou serves as Vice Chairman and Director of Hubei Biocause Pharmaceutical Co., Ltd since June 12, 2020 and its General Manager May 26, 2020.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Vice Chairman & GM | 4.4yrs | CN¥2.02m | no data | |
| CFO & Director | 4.4yrs | CN¥651.00k | no data | |
| Secretary of the Board & Non-Independent Director | 4.4yrs | CN¥301.00k | no data | |
| Chairman of the Board of Directors | 9.7yrs | no data | 10.47% CN¥ 2.1b | |
| Chairman of the Supervisory Board | 6.6yrs | no data | no data | |
| Employee Supervisor | 4.6yrs | no data | no data | |
| Supervisor | 1.5yrs | no data | no data |
4.4yrs
Average Tenure
52yo
Average Age
Experienced Board: 000627's board of directors are considered experienced (4.4 years average tenure).